First Manhattan CO Kala Pharmaceuticals, Inc. Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $1,310 - $2,715	500 Added 35.71%	1,900 $4,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $7,083 - $11,410	1,400 New	1,400 $7,000
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $1,874 - $3,102	-225 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$3.83 - $8.79 $1.81 Million - $4.16 Million	-473,264 Reduced 99.95%	225 $1,000
Q4 2019 Feb 13, 2020	BUY	$3.36 - $4.81 $1.59 Million - $2.28 Million	473,489 New	473,489 $1.75 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.